CA 125 antigen (CA125 II) immunoradiometric assay kit RIA
Overview
Differentially diagnosis ovarian tumors
Evaluate initial treatment efficacy
Detect relapses or metastasis early
Decide to undertake second-look surgery
Monitor long-term patients in remission
Benefits
- ACCURATE AND RELIABLE ASSAY
Assay principle: sandwich
Two monoclonal anti-CA 125 antibodies* are used in the sandwich. The first monoclonal antibody is coated onto the ELSA solid phase, the second one radiolabeled with iodine-125, is used as the tracer.
One-step assay procedure: 18 to 22h at RT.
*Fujirebio Diagnostics antibodies
Features
Working range: 0 - 500 U/mL
Sample: serum or non-citrated plasma – 100 µL
Analytical sensitivity: 0.5 U/mL
Normal values
Number of healthy adults | Concentration range (U/mL) | % of values |
---|---|---|
91 | <25 | 96 |
95 | <35 | 100 |
Immunoassays RIA and ELISA - Catalog
Immuno-analyse RIA et ELISA - Catalog
Annual availability Schedule 2021
In-vitro RIA products - Availability calendar
Calendrier de mise a disposition 2021
Trousse pour radioimmunologie - Availability calendar
Certificat CA125 / ELSA-CA125II
ELSA-CA125II - Certificat
Safety Data Sheet (DEU) CA125 / ELSA-CA125II
ELSA-CA125II - Safety Data Sheet
Safety Data Sheet (ELL) CA125 / ELSA-CA125II
ELSA-CA125II - Safety Data Sheet
Safety Data Sheet (SPA) CA125 / ELSA-CA125II
ELSA-CA125II - Safety Data Sheet
Safety Data Sheet (ENG-GB) CA125 / ELSA-CA125II
ELSA-CA125II - Safety Data Sheet
Safety Data Sheet (ENG-US) CA125 / ELSA-CA125II
ELSA-CA125II - Safety Data Sheet
Safety Data Sheet (FRA-FR) CA125 / ELSA-CA125II
ELSA-CA125II - Safety Data Sheet
Safety Data Sheet (ITA) CA125 / ELSA-CA125II
ELSA-CA125II - Safety Data Sheet
Quality Control Report CA125 / ELSA-CA125II
ELSA-CA125II Batch 438A(18-22h) - Quality Control Report
Quality Control Report CA125 / ELSA-CA125II
ELSA-CA125II Batch 439A(18-22h) - Quality Control Report